DE602006003420D1 - Virusreinigung mit ultrafiltration - Google Patents

Virusreinigung mit ultrafiltration

Info

Publication number
DE602006003420D1
DE602006003420D1 DE602006003420T DE602006003420T DE602006003420D1 DE 602006003420 D1 DE602006003420 D1 DE 602006003420D1 DE 602006003420 T DE602006003420 T DE 602006003420T DE 602006003420 T DE602006003420 T DE 602006003420T DE 602006003420 D1 DE602006003420 D1 DE 602006003420D1
Authority
DE
Germany
Prior art keywords
ultra filtration
virus
virus cleaning
cleaning
adenovirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006003420T
Other languages
English (en)
Inventor
Miranda Weggeman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Vaccines and Prevention BV
Original Assignee
Crucell Holand BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36572264&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602006003420(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Crucell Holand BV filed Critical Crucell Holand BV
Publication of DE602006003420D1 publication Critical patent/DE602006003420D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10051—Methods of production or purification of viral material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
DE602006003420T 2005-04-11 2006-04-11 Virusreinigung mit ultrafiltration Active DE602006003420D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67006405P 2005-04-11 2005-04-11
EP05102842 2005-04-11
PCT/EP2006/003722 WO2006108707A1 (en) 2005-04-11 2006-04-11 Virus purification using ultrafiltration

Publications (1)

Publication Number Publication Date
DE602006003420D1 true DE602006003420D1 (de) 2008-12-11

Family

ID=36572264

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006003420T Active DE602006003420D1 (de) 2005-04-11 2006-04-11 Virusreinigung mit ultrafiltration

Country Status (10)

Country Link
US (1) US8574595B2 (de)
EP (1) EP1869171B2 (de)
CN (1) CN101155915B (de)
AT (1) ATE412737T1 (de)
AU (1) AU2006233800B2 (de)
CA (1) CA2602944C (de)
DE (1) DE602006003420D1 (de)
DK (1) DK1869171T4 (de)
ES (1) ES2317517T5 (de)
WO (1) WO2006108707A1 (de)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008518632A (ja) * 2004-11-03 2008-06-05 イントロゲン セラピューティックス， インコーポレイテッド アデノウイルスベクターの製造および精製のための新規方法
EP1998804B1 (de) * 2006-03-27 2014-04-16 Crucell Holland B.V. Zusammensetzungen, die einen rekombinanten adenovirus und ein adjuvans umfassen
FR2907453B1 (fr) 2006-10-24 2008-12-26 Sanofi Aventis Sa Nouveaux derives du fluorene,compositions les contenant et utilisation
US20080131955A1 (en) * 2006-11-30 2008-06-05 Canon U.S. Life Sciences, Inc. Method of Separating Target DNA from Mixed DNA
PL2195418T3 (pl) * 2007-10-02 2013-05-31 Ptc Phage Tech Center Gmbh Sposób i układ do oczyszczania na skalę przemysłową bakteriofagów z przeznaczeniem do terapii bakteriofagowej
BRPI0821599A2 (pt) * 2007-12-28 2015-06-16 Baxter Int Método de filtração de uma mistura líquida de proteína
US10273502B2 (en) * 2008-06-18 2019-04-30 Oxford Biomedica (Uk) Limited Virus purification
DK2350268T3 (en) * 2008-11-03 2015-03-23 Crucell Holland Bv PROCEDURE FOR PRODUCING ADENOVIRUS VECTORS
FR2944292B1 (fr) 2009-04-08 2013-08-23 Sanofi Pasteur Procede de purification du virus rabique
EA028875B1 (ru) 2009-10-15 2018-01-31 Янссен Вэксинс Энд Превеншн Б.В. Способ очистки аденовирусных частиц из клеточной суспензии
CN102791852B (zh) 2009-10-15 2014-05-07 克鲁塞尔荷兰公司 纯化腺病毒颗粒的方法
KR101820980B1 (ko) 2010-02-15 2018-01-22 얀센 백신스 앤드 프리벤션 비.브이. Ａｄ 26 아데노바이러스 벡터를 제조하는 방법
BR112012026095A2 (pt) 2010-04-14 2015-09-15 Emd Millipore Corp métodos de produção de estoques de vírus de alta pureza e altos títulos e métodos de uso dos mesmos.
PT2575872T (pt) * 2010-06-01 2020-11-19 Seqirus Uk Ltd Concentração de antigénios da vacina da gripe sem liofilização
CN103052399B (zh) * 2010-08-12 2016-06-29 依生生物制药控股有限公司 用于减少病毒组合物中dna杂质的方法
AP3390A (en) 2010-09-20 2015-08-31 Crucell Holland Bv Therapeutic vaccination against active tuberculosis
CA2809463C (en) 2010-09-27 2021-05-25 Crucell Holland B.V. Heterologous prime boost vaccination regimen against malaria
WO2012134987A1 (en) 2011-03-25 2012-10-04 Genentech, Inc. Novel protein purification methods
PL2739293T3 (pl) * 2011-08-05 2020-11-16 Sillajen Biotherapeutics, Inc. Sposoby i kompozycje wytwarzania wirusa krowianki
CN102688485A (zh) * 2011-09-16 2012-09-26 扬州优邦生物制药有限公司 一种猪细小病毒灭活疫苗的制备方法
US20130122038A1 (en) 2011-11-14 2013-05-16 The United States Of America As Represented By The Secretary Of The Department Heterologous prime-boost immunization using measles virus-based vaccines
WO2013106337A1 (en) * 2012-01-09 2013-07-18 Sanofi Pasteur Biologics, Llc Purification of flaviviruses
US8932607B2 (en) 2012-03-12 2015-01-13 Crucell Holland B.V. Batches of recombinant adenovirus with altered terminal ends
WO2013135615A1 (en) 2012-03-12 2013-09-19 Crucell Holland B.V. Batches of recombinant adenovirus with altered terminal ends
US9119813B2 (en) 2012-03-22 2015-09-01 Crucell Holland B.V. Vaccine against RSV
CA2867955C (en) 2012-03-22 2023-02-07 Crucell Holland B.V. Vaccine against rsv
CN103923883A (zh) * 2013-01-16 2014-07-16 辽宁成大生物股份有限公司 一种流感病毒的浓缩、纯化方法
AP2015008815A0 (en) 2013-04-25 2015-10-31 Crucell Holland Bv Stabilized soluble prefusion rsv f polypeptides
PE20160045A1 (es) 2013-06-17 2016-02-18 Crucell Holland Bv Polipeptidos f de prefusion del virus sincicial respiratorio (rsv) solubles y estabilizados
US11066678B2 (en) 2013-07-18 2021-07-20 Children's Hospital Medical Center Methods of improving titer in transfection-based production systems using eukaryotic cells
CN103601793A (zh) * 2013-10-23 2014-02-26 乾元浩生物股份有限公司 一种禽用疫苗抗原纯化的方法
CN112588116A (zh) * 2014-05-13 2021-04-02 美国安进公司 用于过滤器和过滤过程的过程控制系统和方法
WO2015179598A2 (en) 2014-05-21 2015-11-26 Freeslate, Inc. Systems and methods for exchange of buffer solutions
EP3172317B1 (de) * 2014-07-24 2019-05-01 Janssen Vaccines & Prevention B.V. Verfahren zur reinigung von poliovirus aus zellkulturen
EP3283634B1 (de) 2015-04-14 2019-05-22 Janssen Vaccines & Prevention B.V. Rekombinantes adenovirus mit expression von zwei transgenen mit einem bidirektionalen promotor
WO2017005848A1 (en) 2015-07-07 2017-01-12 Janssen Vaccines & Prevention B.V. Stabilized soluble pre-fusion rsv f polypeptides
CN116059336A (zh) 2015-07-07 2023-05-05 扬森疫苗与预防公司 针对rsv的疫苗
SI3439672T1 (sl) 2016-04-05 2021-02-26 Janssen Vaccines & Prevention B.V. Stabiliziran topen pre-fuzijski F protein RSV za uporabo v profilaksi okužbe z RSV
KR102401247B1 (ko) 2016-04-05 2022-05-25 얀센 백신스 앤드 프리벤션 비.브이. Rsv에 대한 백신
RU2758238C2 (ru) 2016-05-12 2021-10-26 Янссен Вэксинс Энд Превеншн Б.В. Эффективный и сбалансированный двунаправленный промотор
MX2018014699A (es) 2016-05-30 2019-02-28 Janssen Vaccines & Prevention Bv Proteinas f de prefusion del vrs estabilizadas.
EP3472327B1 (de) 2016-06-20 2020-08-19 Janssen Vaccines & Prevention B.V. Potenter und ausbalancierter bidirektionaler promotor
JP7229151B2 (ja) 2016-07-14 2023-02-27 ヤンセン ファッシンズ アンド プリベンション ベーフェー Ｈｐｖワクチン
WO2018115308A1 (en) * 2016-12-22 2018-06-28 Blue Sky Vaccines Gmbh Method for purifying virus
KR102111244B1 (ko) 2017-02-09 2020-05-15 얀센 백신스 앤드 프리벤션 비.브이. 이종 유전자의 발현을 위한 강력한 짧은 프로모터
CA3063289A1 (en) * 2017-05-15 2018-11-22 C-Lecta Gmbh Enzyme products
AU2018267971A1 (en) 2017-05-17 2019-11-07 Janssen Vaccines & Prevention B.V. Methods and compositions for inducing protective immunity against RSV infection
CN107603959A (zh) * 2017-08-30 2018-01-19 四川大学 提高缓冲液盐离子浓度纯化病毒的方法
EA202090738A1 (ru) 2017-09-15 2020-06-10 Янссен Вэксинс Энд Превеншн Б.В. Способ безопасного индуцирования иммунитета против rsv
GB201806736D0 (en) * 2018-04-25 2018-06-06 Ge Healthcare Bioprocess R&D Ab Method for virus purification
CN111454914A (zh) * 2019-01-18 2020-07-28 嘉兴安宇生物科技有限公司 一种腺病毒快速纯化方法
KR20220008300A (ko) * 2019-05-14 2022-01-20 얀센 바이오테크 인코포레이티드 정용여과 공정을 사용한 효율적인 불순물 제거
CN110129287B (zh) * 2019-05-15 2023-07-14 青岛蔚蓝生物制品有限公司 一种猪伪狂犬病毒双重超滤系统及纯化方法
CN111394390A (zh) * 2020-03-26 2020-07-10 赛诺（深圳）生物医药研究有限公司 用于新型冠状病毒基因疫苗的批量生产重组腺病毒的方法
CN111575244B (zh) * 2020-05-06 2021-07-23 江苏金迪克生物技术股份有限公司 一种低Vero细胞残留DNA狂犬病疫苗原液的制备方法
CN112226418B (zh) * 2020-09-25 2022-07-08 阜外华中心血管病医院 重组腺相关病毒纯化方法
JP2023552470A (ja) * 2020-12-10 2023-12-15 アストラゼネカ・ユーケイ・リミテッド アデノウイルスの精製方法
CN112899242A (zh) * 2021-02-03 2021-06-04 苏州博腾生物制药有限公司 慢病毒纯化工艺
CN113373120B (zh) * 2021-06-18 2022-04-26 浙江康佰裕生物科技有限公司 Gmp级逆转录病毒载体的纯化方法与应用
CN113817689B (zh) * 2021-11-22 2023-10-03 北京艺妙神州医药科技有限公司 慢病毒纯化工艺
CN115747017B (zh) * 2022-10-25 2023-06-09 上海华新生物高技术有限公司 一种腺病毒纯化装置

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE434914B (sv) * 1975-07-07 1984-08-27 Jonsson U R S Forfarande for att ur en suspension av bakterier och ett vetskeformigt medium genom filtrering avskilja mediet under samtidig anrikning av bakterierna
US4435289A (en) * 1981-12-23 1984-03-06 Romicon, Inc. Series ultrafiltration with pressurized permeate
US5173418A (en) * 1985-05-10 1992-12-22 Benzon Pharma, A/S Production in Escherichia coli of extracellular Serratia spp. hydrolases
US4808315A (en) * 1986-04-28 1989-02-28 Asahi Kasei Kogyo Kabushiki Kaisha Porous hollow fiber membrane and a method for the removal of a virus by using the same
FR2705686B1 (fr) * 1993-05-28 1995-08-18 Transgene Sa Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
FR2716682B1 (fr) * 1994-01-28 1996-04-26 Centre Nat Rech Scient Procédé de préparation de virus adéno-associés (AAV) recombinants et utilisations.
US5851806A (en) * 1994-06-10 1998-12-22 Genvec, Inc. Complementary adenoviral systems and cell lines
EP1548118A2 (de) * 1994-06-10 2005-06-29 Genvec, Inc. Komplementäre adenovirale Vektor-Systeme und Zelllinien
SE9500724D0 (sv) 1994-06-23 1995-02-24 Pharmacia Ab Filtrering
US5559099A (en) * 1994-09-08 1996-09-24 Genvec, Inc. Penton base protein and methods of using same
US5846782A (en) * 1995-11-28 1998-12-08 Genvec, Inc. Targeting adenovirus with use of constrained peptide motifs
US5965541A (en) * 1995-11-28 1999-10-12 Genvec, Inc. Vectors and methods for gene transfer to cells
US6146873A (en) * 1994-11-10 2000-11-14 Baxter Aktiengesellschaft Production of orthomyxoviruses in monkey kidney cells using protein-free media
US5770442A (en) 1995-02-21 1998-06-23 Cornell Research Foundation, Inc. Chimeric adenoviral fiber protein and methods of using same
US5837520A (en) * 1995-03-07 1998-11-17 Canji, Inc. Method of purification of viral vectors
ATE278794T1 (de) * 1995-06-15 2004-10-15 Crucell Holland Bv Verpackungssysteme für humane, menschliche adenoviren, zur verwendung in die gentherapie
FR2737730B1 (fr) * 1995-08-10 1997-09-05 Pasteur Merieux Serums Vacc Procede de purification de virus par chromatographie
US5840565A (en) * 1995-08-22 1998-11-24 The Regents Of The University Of California Methods for enhancing the production of viral vaccines in PKR-deficient cell culture
US6143548A (en) 1995-08-30 2000-11-07 Genzyme Corporation Chromatographic purification of adeno-associated virus (AAV)
US5837511A (en) * 1995-10-02 1998-11-17 Cornell Research Foundation, Inc. Non-group C adenoviral vectors
CA2177085C (en) * 1996-04-26 2007-08-14 National Research Council Of Canada Adenovirus e1-complementing cell lines
WO1998000524A1 (fr) * 1996-07-01 1998-01-08 Rhone-Poulenc Rorer S.A. Procede de production d'adenovirus recombinants
FR2751343B1 (fr) * 1996-07-16 1998-12-18 Transgene Sa Procede de conservation de virus recombinants infectieux, suspension aqueuse virale et utilisation comme medicament
US7732129B1 (en) * 1998-12-01 2010-06-08 Crucell Holland B.V. Method for the production and purification of adenoviral vectors
EP0968284B1 (de) 1996-11-20 2006-12-13 Introgen Therapeutics, Inc. Ein verbessertes verfahren zur produktion und reinigung von adenoviralen vektoren
US6261823B1 (en) * 1996-12-13 2001-07-17 Schering Corporation Methods for purifying viruses
EP1731598A1 (de) 1997-01-31 2006-12-13 Schering Corporation Verfahren zur Kultivierung von Zellen und zur Vermehrung von Viren
US6168944B1 (en) * 1997-01-31 2001-01-02 Schering Corporation Methods for cultivating cells and propagating viruses
WO1998039411A1 (en) 1997-03-04 1998-09-11 Baxter International Inc. Adenovirus e1-complementing cell lines
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
US6020191A (en) * 1997-04-14 2000-02-01 Genzyme Corporation Adenoviral vectors capable of facilitating increased persistence of transgene expression
US5947689A (en) * 1997-05-07 1999-09-07 Scilog, Inc. Automated, quantitative, system for filtration of liquids having a pump controller
DK1604685T3 (da) * 1997-08-28 2012-06-18 Cj Cheiljedang Corp Et svækket japansk encephalitisvirus
US6210683B1 (en) 1997-09-05 2001-04-03 Merck & Co., Inc. Stabilizers containing recombinant human serum albumin for live virus vaccines
SK11842000A3 (sk) 1998-02-17 2001-05-10 Schering Corporation Prostriedok obsahujúci vírus, spôsob jeho koncentrácie a purifikácie
US5981225A (en) * 1998-04-16 1999-11-09 Baylor College Of Medicine Gene transfer vector, recombinant adenovirus particles containing the same, method for producing the same and method of use of the same
AU756889B2 (en) * 1998-04-22 2003-01-23 Genvec, Inc. Efficient purification of adenovirus
US5994134A (en) * 1998-05-04 1999-11-30 Canji, Inc. Viral production process
US6113913A (en) * 1998-06-26 2000-09-05 Genvec, Inc. Recombinant adenovirus
US20030017138A1 (en) 1998-07-08 2003-01-23 Menzo Havenga Chimeric adenoviruses
US6342384B1 (en) * 1998-08-21 2002-01-29 The University Of Va Patent Foundation Production of adenoviral vectors using serum-free suspension cell culture in a hollow fiber system
DK1133316T3 (da) 1998-11-16 2009-05-25 Introgen Therapeutics Inc Adenovirus-formulering til genterapi
CN1195057C (zh) * 1998-12-31 2005-03-30 森泰莱昂公司 分离病毒颗粒的方法
US7264958B1 (en) 1999-02-22 2007-09-04 Transgene, S.A. Method for obtaining a purified viral preparation
US6120820A (en) * 1999-02-22 2000-09-19 Land O'lakes, Inc. Method of modifying the color of a dairy material
NZ515582A (en) 1999-05-17 2003-11-28 Crucell Holland B Adenovirus derived gene delivery vehicles comprising at least one element of adenovirus type 35
US6492169B1 (en) * 1999-05-18 2002-12-10 Crucell Holland, B.V. Complementing cell lines
DE19955558C2 (de) 1999-11-18 2003-03-20 Stefan Kochanek Permanente Amniozyten-Zelllinie, ihre Herstellung und Verwendung zur Herstellung von Gentransfervektoren
EP1103610A1 (de) 1999-11-26 2001-05-30 Introgene B.V. Impfstoffherstellung von immortalisierten Säugetierzellinien
CA2399321C (en) 2000-03-07 2013-04-30 Robert K. Evans Adenovirus formulations
US6168941B1 (en) * 2000-04-07 2001-01-02 Genvec, Inc. Method of producing adenoviral vector stocks
DE10022258A1 (de) * 2000-05-08 2001-11-15 Bayer Ag Reinigung von Proteineinschlusskörpern durch Querstrom-Mikrofiltration
WO2002022080A2 (en) 2000-09-15 2002-03-21 Merck & Co., Inc. Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications
US6365395B1 (en) * 2000-11-03 2002-04-02 Millipore Corporation Process for removing protein aggregates and virus from a protein solution
US20020064860A1 (en) 2000-11-29 2002-05-30 Schering Corporation Method for purifying adenoviruses
IL152420A0 (en) 2001-02-23 2003-05-29 Novartis Ag Novel oncolytic adenoviral vectors
ES2355065T3 (es) 2001-03-01 2011-03-22 Bayer Schering Pharma Aktiengesellschaft Concentración y lisis de células infectadas por adenovirus en una sola operación unitaria.
CA2776391C (en) 2001-10-01 2015-03-31 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Development of a preventive vaccine for filovirus infection in primates
WO2003049764A1 (en) 2001-12-12 2003-06-19 Fh Faulding & Co Limited Composition for viral preservation
US20030180936A1 (en) 2002-03-15 2003-09-25 Memarzadeh Bahram Eric Method for the purification, production and formulation of oncolytic adenoviruses
AU2003220531B2 (en) 2002-03-29 2007-11-01 Merck & Co., Inc. Large scale methods of producing adenovirus and adenovirus seed stocks
KR101006594B1 (ko) 2002-04-25 2011-01-07 크루셀 홀란드 비.브이. 안정한 아데노바이러스 벡터 및 그 증식 방법
ATE447037T1 (de) 2002-04-25 2009-11-15 Crucell Holland Bv Mittel und verfahren zur herstellung von adenovirusvektoren
ATE494362T1 (de) * 2002-05-14 2011-01-15 Merck Sharp & Dohme Verfahren zur reinigung von adenovirus
US20050095705A1 (en) 2003-04-15 2005-05-05 Michael Kadan Method for production of oncolytic adenoviruses
CA2529053A1 (en) * 2003-06-18 2004-12-29 Onyx Pharmaceuticals, Inc. Method for purifying virus
EP1718738A2 (de) * 2004-02-23 2006-11-08 Crucell Holland B.V. Verfahren zur reinigung von viren

Also Published As

Publication number Publication date
US20090123989A1 (en) 2009-05-14
US8574595B2 (en) 2013-11-05
EP1869171B1 (de) 2008-10-29
EP1869171B2 (de) 2015-10-14
WO2006108707A1 (en) 2006-10-19
AU2006233800A1 (en) 2006-10-19
ES2317517T5 (es) 2016-01-21
EP1869171A1 (de) 2007-12-26
CN101155915A (zh) 2008-04-02
CA2602944A1 (en) 2006-10-19
ATE412737T1 (de) 2008-11-15
CN101155915B (zh) 2013-12-04
AU2006233800B2 (en) 2011-07-07
DK1869171T3 (da) 2009-02-16
DK1869171T4 (en) 2016-01-18
CA2602944C (en) 2015-08-11
ES2317517T3 (es) 2009-04-16

Similar Documents

Publication Publication Date Title
DE602006003420D1 (de) Virusreinigung mit ultrafiltration
EA201290224A1 (ru) Способы прямого осмотического разделения
EA200702210A1 (ru) Способ очистки белков
CY1119092T1 (el) Συστημα για την επεξεργασια νερου που χρησιμοποιειται για βιομηχανικους σκοπους
NO20071158L (no) Membraner for separasjoner som krever hoy selektivitet
EP3603777A4 (de) Poröse membran zur membrandestillation und verfahren zum betrieb eines membrandestillationsmoduls
EP2808393A3 (de) Fucosylierungsunfähige Zellen
EA201290251A1 (ru) Системы и способы осмотического разделения
SG191089A1 (en) Compositions for separation methods
MY144159A (en) Membrane post treatment
EP1808220A4 (de) Verfahren zur herstellung einer umkehrosomose-verbundmembran
WO2009054226A1 (ja) たんぱく質の精製方法
EP3978102A4 (de) Vorwärtsosmosemembran, vorwärtsosmosemembranmodul und herstellungsverfahren dafür
EP3517201A4 (de) Herstellungsverfahren, regenerationsverfahren und anwendung für chelatbildende mikrofiltrationsmembran
EP2119675A4 (de) Verfahren zur behandlung mit umkehrosmosemembran
WO2004094466A3 (en) Recombinant influenza viruses holding a mutation in a transmembrane protein gene
BR112015006223A2 (pt) unidade de tratamento de água subaquática e método para limpar a dita unidade
WO2011105828A3 (ko) 고다공성 중공사막 및 이의 제조방법
EP2365869A4 (de) Mikroporöse membran und herstellungsverfahren
JP2012021007A5 (de)
FI20050452A0 (fi) Virtauskone, sen liukurengastiiviste, liukurengastiivisteen runkokappale ja menetelmä liukurengastiivisteen kiinnittämiseksi virtauskoneeseen
NZ596671A (en) Assays for influenza virus hemagglutinins
WO2013110087A3 (en) Forward osmosis membrane based on an ipc spacer fabric
MX2010000534A (es) Filtracion por flujo tangencial variable.
EP3950103A4 (de) Poröse membran

Legal Events

Date Code Title Description
8363 Opposition against the patent